Pages that link to "Q37613699"
Jump to navigation
Jump to search
The following pages link to Antibody levels correlate with detection of Trypanosoma cruzi DNA by sensitive polymerase chain reaction assays in seropositive blood donors and possible resolution of infection over time (Q37613699):
Displayed 23 items.
- Commercial enzyme-linked immunosorbent assay versuspolymerase chain reaction for the diagnosis of chronic Chagas disease: a systematic review and meta-analysis (Q26774182) (← links)
- Translational challenges of animal models in Chagas disease drug development: a review (Q26796451) (← links)
- The Impact of Emerging Infectious Diseases on Chinese Blood Safety (Q30240263) (← links)
- Electrocardiographic abnormalities in Trypanosoma cruzi seropositive and seronegative former blood donors (Q34613631) (← links)
- Evaluating Chagas disease progression and cure through blood-derived biomarkers: a systematic review (Q34992879) (← links)
- Genome wide association study (GWAS) of Chagas cardiomyopathy in Trypanosoma cruzi seropositive subjects (Q35063628) (← links)
- Amiodarone and Trypanosoma cruzi parasitemia in patients with Chagas disease. (Q35655994) (← links)
- Cost-Effectiveness of Blood Donation Screening for Trypanosoma cruzi in Mexico. (Q35965823) (← links)
- Development of a Novel Multiplex Immunoassay Multi-cruzi for the Serological Confirmation of Chagas Disease (Q35976295) (← links)
- Inflammatory and cardiac biomarkers are differentially expressed in clinical stages of Chagas disease (Q36904784) (← links)
- Chagas disease research and development: Is there light at the end of the tunnel? (Q37541623) (← links)
- Contribution of the Retrovirus Epidemiology Donor Study (REDS) to research on blood transfusion safety in Brazil (Q37734062) (← links)
- Chagas disease drug discovery: toward a new era. (Q38253281) (← links)
- Detection of Trypanosoma cruzi DNA in blood by PCR is associated with Chagas cardiomyopathy and disease severity (Q39417948) (← links)
- Evidence of meaningful levels of Trypanosoma cruzi in platelet concentrates from seropositive blood donors. (Q41482695) (← links)
- The Significance of Discordant Serology in Chagas Disease: Enhanced T-Cell Immunity to Trypanosoma cruzi in Serodiscordant Subjects (Q41665227) (← links)
- Apheresis in developing countries around the World (Q46114694) (← links)
- Beneficial effects of benznidazole in Chagas disease: NIH SaMi-Trop cohort study (Q58084823) (← links)
- Chagas, a cardiomyopathy emerging from obscurity (Q58842668) (← links)
- Lack of evidence of seronegative infection in an endemic area of Chagas disease (Q64246538) (← links)
- A Parasite Biomarker Set for Evaluating Benznidazole Treatment Efficacy in Patients with Chronic Asymptomatic Trypanosoma cruzi Infection (Q92264459) (← links)
- Gut Dysbiosis in Chagas Disease. A Possible Link to the Pathogenesis (Q99712056) (← links)
- A novel Trypanosoma cruzi secreted antigen as a potential biomarker of Chagas disease (Q101574161) (← links)